Observation on the efficacy and safety of Infergen combined with capsule ribavirin in treatment of hepatitis C patients.
- Author:
Guang-han LUO
1
;
Bo-ming LIAO
;
Shao-biao HUANG
Author Information
1. Department of Infectious Diseases, First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China.
- Publication Type:Journal Article
- MeSH:
Adult;
Antiviral Agents;
administration & dosage;
adverse effects;
Drug Therapy, Combination;
Female;
Follow-Up Studies;
Hepatitis C, Chronic;
drug therapy;
genetics;
Humans;
Interferon Type I;
administration & dosage;
adverse effects;
Interferon-alpha;
Male;
Middle Aged;
RNA, Viral;
blood;
Recombinant Proteins;
Ribavirin;
administration & dosage;
adverse effects;
Safety;
Treatment Outcome;
Viral Load
- From:
Chinese Journal of Hepatology
2004;12(6):363-363
- CountryChina
- Language:Chinese
